714 related articles for article (PubMed ID: 24798476)
1. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
2. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; BenoƮt JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
3. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
4. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
5. Advances in polymeric micelles for drug delivery and tumor targeting.
Kedar U; Phutane P; Shidhaye S; Kadam V
Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
[TBL] [Abstract][Full Text] [Related]
6. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
8. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
9. Potentials and challenges of active targeting at the tumor cells by engineered polymeric nanoparticles.
Mukherjee B; Satapathy BS; Mondal L; Dey NS; Maji R
Curr Pharm Biotechnol; 2013; 14(15):1250-63. PubMed ID: 24910012
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y
Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances.
Meng F; Zhong Y; Cheng R; Deng C; Zhong Z
Nanomedicine (Lond); 2014 Mar; 9(3):487-99. PubMed ID: 24746192
[TBL] [Abstract][Full Text] [Related]
12. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
[TBL] [Abstract][Full Text] [Related]
13. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Cheng R; Meng F; Deng C; Klok HA; Zhong Z
Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
[TBL] [Abstract][Full Text] [Related]
14. Ligand based dendritic systems for tumor targeting.
Agarwal A; Saraf S; Asthana A; Gupta U; Gajbhiye V; Jain NK
Int J Pharm; 2008 Feb; 350(1-2):3-13. PubMed ID: 18162345
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticulate drug delivery systems for cancer chemotherapy.
Saha RN; Vasanthakumar S; Bende G; Snehalatha M
Mol Membr Biol; 2010 Oct; 27(7):215-31. PubMed ID: 20939772
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
Kouchakzadeh H; Safavi MS; Shojaosadati SA
Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoparticles for targeted drug delivery system for cancer therapy.
Masood F
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():569-578. PubMed ID: 26706565
[TBL] [Abstract][Full Text] [Related]
18. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
19. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
20. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]